Cargando…
The Assessment of Tumor Response by Measuring the Single Largest Lesion per Organ in Metastatic Tumors: A Pooled Analysis of Previously Reported Data
Background: The RECIST 1.1 adopted a total of five target lesions to be measured, with a maximum of two lesions per organ. To the best of our knowledge, the criterion of two target lesions per organ in the RECIST 1.1 is arbitrary and has not been supported by any objective evidence. Recently, we rep...
Autores principales: | Jang, Hyun Joo, Cho, Ji Woong, Park, Bumjung, Choi, Hyun Chang, Kim, Hyeong Su, Kim, Jung Han |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280400/ https://www.ncbi.nlm.nih.gov/pubmed/25561982 http://dx.doi.org/10.7150/jca.10912 |
Ejemplares similares
-
Ideal number of target lesions per organ to measure in metastatic colorectal cancer
por: KIM, HYEONG SU, et al.
Publicado: (2014) -
Comparison of RECIST 1.0 and RECIST 1.1 in Patients with Metastatic Cancer: A Pooled Analysis
por: Kim, Jung Han, et al.
Publicado: (2015) -
Tumor response assessment by the single-lesion measurement per organ in small cell lung cancer
por: Jung, Soong Goo, et al.
Publicado: (2016) -
Comparison of the RECIST and PERCIST criteria in solid tumors: a pooled analysis and review
por: Min, Seon Jeong, et al.
Publicado: (2016) -
Histological characteristics of the largest and secondary tumors in radical prostatectomy specimens and implications for focal therapy
por: Choi, Young Hyo, et al.
Publicado: (2019)